성인 혈구탐식성림프조직구증식증의 이해, 진단 및 치료
Hemophagocytic Lymphohistiocytosis in Adults – Overview, Diagnosis, and Treatment
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
혈구탐식성림프조직구증식증(hemophagocytic lymphohistiocytosis,HLH)은 조직구증식증후군(histiocytosis syndrome)에 속하는 질환군[1]으로 고열과 범혈구감소증을 주소로 발병하여 간/비장 등의 장기종대, 간 기능 부전 등 전신을 침범하는 염증반응을 보이는 질환이다. 많은 경우 승압제에 반응하지 않는 혈압 저하를 동반하므로 패혈증을 동반한 감염이라고 판단하여 광범위 항균제를 투여하는 등의 치료가 시행되는 경우가 많으나 이러한 노력에도 임상적인 호전이 없이 심각한 장기 부전으로 진행하기도 하며 이러한 상태에서 뒤늦게 진단되기도 한다.HLH는 과거 주로 소아에서 발병한다고 알려졌으며 발생률은 연간 80만 명당 1명꼴로 국내에서는 연간 62.5명이 발생한다. 성인의 발생률은 정확히 알려지지 않았으나 과거 고열을 동반한 다발성 장기부전 양상을 보인 원인 불명의 중증 환자들 중 상당수가 HLH에 해당하는 것으로 생각되고있다[2].
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome involving defective apoptosis in which the pathways regulating the termination of immune and inflammatory responses are disrupted. Fever, cytopenia, splenomegaly, and hemophagocytosis are typical findings of this syndrome. HLH can be induced by genetic disorders (familial) or secondary causes. While familial HLH is rare, secondary causes include infection, autoimmune disease, and malignancy in adults. Adult onset HLH may be confused with or misdiagnosed as sepsis or macrophage activation syndrome due to similar clinical manifestations and laboratory findings. Consequently, it is difficult to diagnose HLH promptly to initiate adequate immunosuppressive treatment or chemotherapy. A pediatric HLH treatment protocol such as HLH-2004 or multi-agent chemotherapy can be given to adults after adjusting the drug dosage and type. After the initial treatment, refractory or reactivated patients should undergo allogenic hematopoietic stem cell transplantation as soon as possible to improve survival. Clinical trials should determine more suitable therapeutic options for adults with HLH.
참고문헌 (58)
- Filipovich AH, "Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders", Immunol Allergy Clin North Am, 28, pp.293~313,viii (2008)
- Ishii E, "Nationwide survey of hemophagocytic lymphohistiocytosis in Japan", Int J Hematol, 86, pp.58~65 (2007)
- Jordan MB, "How I treat hemophagocytic lymphohistiocytosis", Blood, 118, pp.4041~4052 (2011)
- Egeler RM, "Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis", J Pediatr Hematol Oncol, 18, pp.340~345 (1996)
- Chen JH, "Pathology of the liver in familial hemophagocytic lymphohistiocytosis", Am J Surg Pathol, 34, pp.852~867 (2010)
- Janka G, "Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis", Hematol Oncol Clin North Am, 12, pp.435~444 (1998)
- Machaczka M, "Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center", Leuk Lymphoma, 52, pp.613~619 (2011)
- Machaczka M, "Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma", Med Oncol, 28, pp.539~543 (2011)
- Meki A, "Hemophagocytic lymphohistiocytosis in chronic lymphocytic leukemia", J Clin Oncol, 29, pp.e685~e687 (2011)
- Mulay S, "Successful resolution of acute myelogenous leukemia-associated hemophagocytic lymphohistiocytosis with decitabine", Leuk Lymphoma, 52, pp.341~343 (2011)
- Gholam C, "Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management", Clin Exp Immunol, 163, pp.271~283 (2011)
- Horne A, "Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis", Br J Haematol, 143, pp.75~83 (2008)
- Marsh RA, "STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America", Pediatr Blood Cancer, 55, pp.134~140 (2010)
- Meeths M, "Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D", Blood, 118, pp.5783~5793 (2011)
- Yoon HS, "UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis", Haematologica, 95, pp.622~626 (2010)
- Arico M, "Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene", Blood, 97, pp.1131~1133 (2001)
- Henter JI, "Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocytemediated cytotoxicity and triggering of apoptosis", Med Pediatr Oncol, 38, pp.305~309 (2002)
- Feldmann J, "Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)", Cell, 115, pp.461~473 (2003)
- Nagafuji K, "Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis", Haematologica, 92, pp.978~981 (2007)
- Zhang K, "Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH", Blood, 118, pp.5794~5798 (2011)
- Sumegi J, "Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis", Blood, 117, pp.e151~e160 (2011)
- Sumegi J, "Gene-expression signatures differ between different clinical forms of familial hemophagocytic lymphohistiocytosis", Blood, 121, pp.e14~e24 (2013)
- Henter JI, "HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis", Pediatr Blood Cancer, 48, pp.124~131 (2007)
- Filipovich AH, "Hemophagocytic lymphohistiocytosis (HLH)and related disorders", Hematology Am Soc Hematol Educ Program, 2009, pp.127~131 (2009)
- Raschke RA, "Hemophagocytic lymphohistiocytosis:a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults", Chest, 140, pp.933~938 (2011)
- Félix FH, "Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis", Rheumatol Int, 29, pp.973~974 (2009)
- Gupta A, "The role of hemophagocytosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis", Pediatr Blood Cancer, 50, pp.192~194 (2008)
- Chung HJ, "Establishment of a reference interval for natural killer cell activity through flow cytometry and its clinical application in the diagnosis of hemophagocytic lymphohistiocytosis", Int J Lab Hematol, 32, pp.239~247 (2010)
- Imashuku S, "Soluble interleukin-2 receptor:a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis", Blood, 86, pp.4706~4707 (1995)
- Allen CE, "Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis", Pediatr Blood Cancer, 50, pp.1227~1235 (2008)
- Schram AM, "Marked hyperferritinemia does not predict for HLH in the adult population", Blood, 125, pp.1548~1552 (2015)
- Imashuku S, "Advances in the management of hemophagocytic lymphohistiocytosis", Int J Hematol, 72, pp.1~11 (2000)
- Henter JI, "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation", Blood, 100, pp.2367~2373 (2002)
- Aricò M, "Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society.", Leukemia, 10, pp.197~203 (1996)
- Baker KS, "Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation", Blood, 89, pp.3857~3863 (1997)
- Cesaro S, "Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis:a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP)", Haematologica, 93, pp.1694~1701 (2008)
- Horne A, "Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis", Br J Haematol, 129, pp.622~630 (2005)
- Jabado N, "Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors", Blood, 90, pp.4743~4748 (1997)
- Cooper N, "Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis", Blood, 107, pp.1233~1236 (2006)
- Marsh RA, "Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation", Blood, 116, pp.5824~5831 (2010)
- Mahlaoui N, "Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients", Pediatrics, 120, pp.e622~e628 (2007)
- Balamuth NJ, "Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis", J Pediatr Hematol Oncol, 29, pp.569~573 (2007)
- Ideguchi H, "Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab", Rheumatology (Oxford), 46, pp.1621~1622 (2007)
- Buyse S, "Critical care management of patients with hemophagocytic lymphohistiocytosis", Intensive Care Med, 36, pp.1695~1702 (2010)
- Imashuku S, "Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center", Med Pediatr Oncol, 41, pp.103~109 (2003)
- Park HS, "Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors", Ann Hematol, 91, pp.897~904 (2012)
- 신호진, "Treatment Outcomes with CHOP Chemotherapy in Adult Patients with Hemophagocytic Lymphohistiocytosis", Journal of Korean Medical Science, 23(3), pp.439~444 (2008), 대한의학회
- Tseng YT, "Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults", J Microbiol Immunol Infect, 44, pp.191~197 (2011)
- Ahn JS, "Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis", Am J Hematol, 85, pp.719~722 (2010)
- Jin YK, "Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China", Chin Med J (Engl), 123, pp.1426~1430 (2010)
- Belyea B, "Spontaneous resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis", Pediatr Blood Cancer, 55, pp.754~756 (2010)
- Gupta AA, "Experience with hemophagocytic lymphohistiocytosis", macrophage activation syndrome at a single institution, 2009, pp.31, 81~84
- Imashuku S, "Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010", J Pediatr Hematol Oncol, 33, pp.35~39 (2011)
- Lin TF, "Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality", Pediatr Blood Cancer, 56, pp.154~155 (2011)
- Takada H, "Interleukin-18 in hemophagocytic lymphohistiocytosis", Leuk Lymphoma, 42, pp.21~28 (2001)
- Otrock ZK, "Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis", Am J Hematol, 90, pp.220~224 (2015)
- Rivière S, "Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients", Am J Med, 127, pp.1118~1125 (2014)
- Imashuku S, "Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis", J Clin Oncol, 19, pp.2665~2673 (2001)
